Sphingolipid content in the human uterus and pair-matched uterine leiomyomas remains constant

3Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the present work we sought to investigate the content of sphingolipids (sphingosine, sphinganine, sphingosine-1-phosphate and ceramide) in human fibroids and pair-matched healthy uterus tissue. We demonstrated that, in uterine leiomyomas, the contents of sphingosine, sphinganine, sphingosine-1-phosphate and ceramide remains quite constant. However, a trend towards elevation of ceramide and simultaneous reduction of sphingosine-1 phosphate levels was also noticed. Additionally, in uterine leiomyomas we found relevant activation of both PTEN and MAPK(ERK1/2) signaling pathways with only a minor change in AKT activity and relatively absent HIF-1α/AMPK activation. In conclusion, rather modest changes in sphingolipids are correlated with the activation of PTEN and MAPK(ERK1/2) signaling proteins in human uterine leiomyomas. © 2012 AOCS.

Cite

CITATION STYLE

APA

Paweł, K., Chabowski, A., & Górski, J. (2013). Sphingolipid content in the human uterus and pair-matched uterine leiomyomas remains constant. Lipids, 48(3), 245–250. https://doi.org/10.1007/s11745-012-3746-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free